Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases. | Nagoya J Med Sci;85(1): 33-34, 2023 02. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases.

Maeda, Osamu.

Affiliation

Maeda O; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.

Nagoya J Med Sci ; 85(1): 33-34, 2023 02.

Article in En | MEDLINE | ID: mdl-36923631

Subject(s)

Melanoma; Myasthenia Gravis; Humans; Nivolumab/therapeutic use; Immune Checkpoint Inhibitors/therapeutic use; Melanoma/drug therapy; Melanoma/immunology; Melanoma, Cutaneous Malignant

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma / Myasthenia Gravis Limits: Humans Language: En Journal: Nagoya J Med Sci Year: 2023 Document type: Article Affiliation country: Japan

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma / Myasthenia Gravis Limits: Humans Language: En Journal: Nagoya J Med Sci Year: 2023 Document type: Article Affiliation country: Japan